Janus Kinase 2, antagonists & inhibitors
- Name
- Janus Kinase 2, antagonists & inhibitors
- Accession Number
- DBCAT002779
- Description
Not Available
- Drugs
Drug Drug Description Pacritinib A kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts. AZD-1480 AZD1480 has been used in trials studying the treatment of Solid Malignancies, Post-Polycythaemia Vera, Primary Myelofibrosis (PMF), and Essential Thrombocythaemia Myelofibrosis. BMS-911543 BMS-911543 has been used in trials studying the treatment of Cancer. Gandotinib Gandotinib has been used in trials studying the treatment of Myelofibrosis, Polycythemia Vera, Primary Myelofibrosis, Thrombocythemia, Essential, and Myeloproliferative Disorders, among others. - Drugs & Drug Targets
Drug Target Type Pacritinib Cytochrome P450 3A4 enzyme Pacritinib Cytochrome P450 1A2 enzyme Pacritinib Tyrosine-protein kinase JAK2 target Pacritinib Receptor-type tyrosine-protein kinase FLT3 target Pacritinib P-glycoprotein 1 transporter Pacritinib ATP-binding cassette sub-family G member 2 transporter Pacritinib Solute carrier family 22 member 1 transporter Pacritinib Cytochrome P450 2C19 enzyme Pacritinib Solute carrier family 22 member 2 transporter